Clinical Trials Directory

Trials / Completed

CompletedNCT01638182

Biocomparison Study

Comparison of Effects of Nutritional Doses Vitamin K1 and K2 on Carboxylation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

The effects of two vitamin K-forms on carboxylation of the vitamin K-dependent proteins osteocalcin and matrix-gla protein will be compared after supplementing these vitamins in a nutritional dose range. The investigators hypothesized that MK-7 is more effective than K1 at a dose comparable to the RDA of vitamin K.

Detailed description

Vitamin K is a group name for the naturally occurring phylloquinone (K1) and menaquinones (MK-n; K2). The latter can be subdivided into the short-chain (e.g. MK-4) and the long-chain (e.g. MK-7, MK-8, and MK-9) menaquinones. Earlier studies have shown that high vitamin K intake leads to improved bone and vascular health by increased carboxylation of vitamin K-dependent proteins in these tissues. In the dietary range, MK-7 has been suggested to be the most effective cofactor for the carboxylation of Gla-proteins, such as osteocalcin (OC) and matrix-Gla protein (MGP).Until now, no randomized controlled trial has compared the efficacy of K1 versus MK-7 in a nutritional dose range. The investigators are therefore interested to compare the effects of K1 and MK-7 on OC and MGP carboxylation after supplementing these vitamins at a dose not exceeding the RDA.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlacebo27 participants received for three months 1 placebo capsule per day
DIETARY_SUPPLEMENTVitamin K1-capsules27 participants received for 3 months 1 vitamin K1-capsule per day containing 52 µg of K1/day
DIETARY_SUPPLEMENTVitamin K2-capsules27 participants received for 3 months 1 vitamin K2-capsule per day containing 75 µg of MK-7.

Timeline

Start date
2011-03-01
Primary completion
2011-06-01
Completion
2011-09-01
First posted
2012-07-11
Last updated
2012-07-11

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01638182. Inclusion in this directory is not an endorsement.